Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Osteoporotic Fractures | 10 | 2022 | 410 | 2.110 |
Why?
|
Spinal Fractures | 9 | 2022 | 704 | 1.750 |
Why?
|
Gait | 11 | 2022 | 810 | 1.480 |
Why?
|
Movement | 8 | 2019 | 1476 | 1.320 |
Why?
|
Fractures, Compression | 4 | 2019 | 131 | 1.230 |
Why?
|
Geriatric Assessment | 5 | 2014 | 1409 | 1.050 |
Why?
|
Silver | 1 | 2024 | 117 | 0.900 |
Why?
|
Spinal Fusion | 10 | 2020 | 1294 | 0.880 |
Why?
|
Scoliosis | 8 | 2023 | 790 | 0.880 |
Why?
|
Fractures, Spontaneous | 1 | 2024 | 231 | 0.830 |
Why?
|
Muscle Strength | 4 | 2023 | 624 | 0.830 |
Why?
|
Teriparatide | 4 | 2022 | 226 | 0.830 |
Why?
|
Thoracic Vertebrae | 9 | 2022 | 612 | 0.800 |
Why?
|
Posture | 4 | 2014 | 956 | 0.800 |
Why?
|
Ankle | 2 | 2023 | 350 | 0.760 |
Why?
|
Alendronate | 2 | 2020 | 174 | 0.670 |
Why?
|
Spondylitis | 2 | 2021 | 20 | 0.620 |
Why?
|
Polysaccharides | 1 | 2024 | 1014 | 0.590 |
Why?
|
Skin Pigmentation | 1 | 2019 | 277 | 0.570 |
Why?
|
Fibrin Tissue Adhesive | 1 | 2017 | 86 | 0.570 |
Why?
|
Bone Density Conservation Agents | 3 | 2022 | 793 | 0.560 |
Why?
|
Isometric Contraction | 3 | 2015 | 150 | 0.550 |
Why?
|
Fracture Healing | 2 | 2017 | 445 | 0.550 |
Why?
|
Dogs | 5 | 2011 | 3832 | 0.540 |
Why?
|
Bone Malalignment | 1 | 2016 | 38 | 0.540 |
Why?
|
Lumbar Vertebrae | 9 | 2022 | 1876 | 0.530 |
Why?
|
Palladium | 2 | 2014 | 67 | 0.530 |
Why?
|
Conjunctivitis | 1 | 2017 | 155 | 0.520 |
Why?
|
Antiviral Agents | 2 | 2024 | 3048 | 0.510 |
Why?
|
Dura Mater | 1 | 2017 | 290 | 0.500 |
Why?
|
Doxycycline | 1 | 2017 | 344 | 0.490 |
Why?
|
Absorbable Implants | 1 | 2017 | 338 | 0.490 |
Why?
|
Lysergic Acid | 2 | 2011 | 2 | 0.480 |
Why?
|
Kyphosis | 4 | 2021 | 251 | 0.480 |
Why?
|
Axons | 8 | 2010 | 1671 | 0.480 |
Why?
|
Arthroplasty, Replacement, Knee | 2 | 2022 | 1394 | 0.460 |
Why?
|
Cervical Vertebrae | 3 | 2021 | 976 | 0.440 |
Why?
|
Upper Extremity | 2 | 2019 | 658 | 0.430 |
Why?
|
Sex Characteristics | 1 | 2023 | 2640 | 0.430 |
Why?
|
Gonorrhea | 1 | 2017 | 346 | 0.420 |
Why?
|
Granulocyte Colony-Stimulating Factor | 3 | 2011 | 629 | 0.410 |
Why?
|
Occipital Bone | 1 | 2012 | 55 | 0.400 |
Why?
|
Atlanto-Occipital Joint | 1 | 2012 | 33 | 0.400 |
Why?
|
Low Back Pain | 1 | 2020 | 983 | 0.390 |
Why?
|
Dietary Fats | 1 | 2019 | 1994 | 0.380 |
Why?
|
Pyramidal Tracts | 2 | 2010 | 251 | 0.380 |
Why?
|
Ethylene Oxide | 1 | 2011 | 28 | 0.380 |
Why?
|
Brain Injuries | 9 | 2010 | 2054 | 0.370 |
Why?
|
Thorax | 1 | 2014 | 555 | 0.360 |
Why?
|
Contingent Negative Variation | 1 | 2010 | 36 | 0.360 |
Why?
|
Activities of Daily Living | 4 | 2022 | 2420 | 0.350 |
Why?
|
Mycoses | 1 | 2013 | 386 | 0.340 |
Why?
|
Muscle, Skeletal | 5 | 2023 | 4947 | 0.310 |
Why?
|
Indoles | 2 | 2014 | 1830 | 0.300 |
Why?
|
H-Reflex | 2 | 2006 | 25 | 0.290 |
Why?
|
Gait Disorders, Neurologic | 1 | 2010 | 241 | 0.290 |
Why?
|
Aged, 80 and over | 21 | 2024 | 58952 | 0.290 |
Why?
|
Organometallic Compounds | 1 | 2011 | 647 | 0.290 |
Why?
|
Sodium Channels | 3 | 2009 | 339 | 0.290 |
Why?
|
Japan | 8 | 2020 | 1378 | 0.290 |
Why?
|
Spine | 4 | 2022 | 1129 | 0.290 |
Why?
|
Frail Elderly | 1 | 2012 | 766 | 0.280 |
Why?
|
Osteoporosis | 3 | 2022 | 1604 | 0.280 |
Why?
|
Zinc | 1 | 2011 | 672 | 0.280 |
Why?
|
Ganglia, Spinal | 3 | 2006 | 525 | 0.270 |
Why?
|
Male | 61 | 2024 | 360693 | 0.270 |
Why?
|
Neutropenia | 2 | 2011 | 885 | 0.270 |
Why?
|
Aged | 36 | 2024 | 169288 | 0.270 |
Why?
|
Walking | 2 | 2014 | 1194 | 0.270 |
Why?
|
Accidental Falls | 1 | 2014 | 1068 | 0.270 |
Why?
|
Arthroscopy | 1 | 2013 | 969 | 0.260 |
Why?
|
Tissue Survival | 1 | 2006 | 120 | 0.260 |
Why?
|
Muscular Diseases | 1 | 2010 | 552 | 0.250 |
Why?
|
Clusterin | 1 | 2005 | 71 | 0.250 |
Why?
|
Cyclophosphamide | 1 | 2011 | 2219 | 0.250 |
Why?
|
Psychomotor Performance | 3 | 2010 | 1880 | 0.240 |
Why?
|
Spinal Stenosis | 2 | 2018 | 261 | 0.240 |
Why?
|
Time and Motion Studies | 2 | 2022 | 143 | 0.240 |
Why?
|
Decompression, Surgical | 3 | 2020 | 607 | 0.240 |
Why?
|
Microbial Sensitivity Tests | 2 | 2024 | 1936 | 0.240 |
Why?
|
Female | 58 | 2024 | 392544 | 0.240 |
Why?
|
2',5'-Oligoadenylate Synthetase | 1 | 2004 | 25 | 0.240 |
Why?
|
Anti-Bacterial Agents | 3 | 2024 | 7407 | 0.230 |
Why?
|
Tetrodotoxin | 2 | 2009 | 245 | 0.230 |
Why?
|
Trauma, Nervous System | 1 | 2004 | 35 | 0.230 |
Why?
|
Knee Joint | 4 | 2018 | 1678 | 0.230 |
Why?
|
Staphylococcus epidermidis | 1 | 2024 | 123 | 0.230 |
Why?
|
Physical Therapy Modalities | 4 | 2019 | 531 | 0.230 |
Why?
|
Cell Transplantation | 1 | 2006 | 472 | 0.220 |
Why?
|
Sulfates | 1 | 2024 | 378 | 0.220 |
Why?
|
Arm | 1 | 2006 | 589 | 0.220 |
Why?
|
Interferons | 1 | 2007 | 702 | 0.220 |
Why?
|
Motor Cortex | 1 | 2010 | 1006 | 0.210 |
Why?
|
Apolipoproteins E | 2 | 2005 | 1443 | 0.200 |
Why?
|
Middle Aged | 32 | 2024 | 220853 | 0.200 |
Why?
|
Catalysis | 3 | 2014 | 763 | 0.200 |
Why?
|
Ossification of Posterior Longitudinal Ligament | 1 | 2022 | 17 | 0.200 |
Why?
|
Discitis | 1 | 2022 | 45 | 0.200 |
Why?
|
Ligamentum Flavum | 1 | 2022 | 20 | 0.200 |
Why?
|
Range of Motion, Articular | 4 | 2019 | 1590 | 0.200 |
Why?
|
Hepatitis C, Chronic | 2 | 2007 | 1027 | 0.200 |
Why?
|
Humans | 64 | 2024 | 761208 | 0.190 |
Why?
|
Diet | 1 | 2019 | 8048 | 0.190 |
Why?
|
Ankle Joint | 2 | 2023 | 446 | 0.190 |
Why?
|
Orthopedic Fixation Devices | 1 | 2021 | 77 | 0.190 |
Why?
|
Regeneration | 1 | 2010 | 1505 | 0.190 |
Why?
|
Peptide Hydrolases | 1 | 2004 | 616 | 0.180 |
Why?
|
Sarcoma | 2 | 2023 | 1800 | 0.180 |
Why?
|
Femoral Fractures | 1 | 2024 | 375 | 0.180 |
Why?
|
Postural Balance | 2 | 2022 | 623 | 0.180 |
Why?
|
Liposarcoma | 1 | 2023 | 289 | 0.170 |
Why?
|
Postoperative Period | 2 | 2022 | 1818 | 0.170 |
Why?
|
Retrospective Studies | 22 | 2024 | 80674 | 0.170 |
Why?
|
Escherichia coli | 3 | 2024 | 4201 | 0.170 |
Why?
|
Xanthophylls | 1 | 2019 | 94 | 0.170 |
Why?
|
Muscle Fibers, Skeletal | 2 | 2015 | 543 | 0.170 |
Why?
|
Mobility Limitation | 2 | 2014 | 408 | 0.160 |
Why?
|
Vertebroplasty | 1 | 2020 | 78 | 0.160 |
Why?
|
Ossification, Heterotopic | 1 | 2022 | 235 | 0.160 |
Why?
|
Rats | 15 | 2015 | 23704 | 0.160 |
Why?
|
Up-Regulation | 2 | 2005 | 4111 | 0.160 |
Why?
|
Tissue Engineering | 2 | 2006 | 1865 | 0.160 |
Why?
|
Biological Availability | 1 | 2019 | 389 | 0.160 |
Why?
|
Electromyography | 5 | 2015 | 1393 | 0.150 |
Why?
|
Rats, Sprague-Dawley | 10 | 2010 | 8164 | 0.150 |
Why?
|
Amyloid beta-Peptides | 4 | 2005 | 3840 | 0.150 |
Why?
|
Amyloid beta-Protein Precursor | 2 | 2003 | 1111 | 0.150 |
Why?
|
Spinal Cord Injuries | 1 | 2006 | 924 | 0.150 |
Why?
|
Postoperative Complications | 6 | 2022 | 15637 | 0.150 |
Why?
|
Decision Support Systems, Clinical | 1 | 2007 | 1172 | 0.150 |
Why?
|
Lower Extremity | 2 | 2016 | 1201 | 0.140 |
Why?
|
Prednisolone | 1 | 2018 | 324 | 0.140 |
Why?
|
Blood Loss, Surgical | 1 | 2021 | 637 | 0.140 |
Why?
|
Animals | 30 | 2024 | 168079 | 0.140 |
Why?
|
Anti-Infective Agents | 1 | 2024 | 983 | 0.140 |
Why?
|
Cyclization | 2 | 2014 | 58 | 0.140 |
Why?
|
Actinobacillus pleuropneumoniae | 1 | 2016 | 8 | 0.140 |
Why?
|
Zygapophyseal Joint | 1 | 2018 | 127 | 0.140 |
Why?
|
Spondylolisthesis | 1 | 2018 | 172 | 0.130 |
Why?
|
Carotenoids | 1 | 2019 | 621 | 0.130 |
Why?
|
Oxidation-Reduction | 2 | 2014 | 2227 | 0.130 |
Why?
|
Genome-Wide Association Study | 4 | 2023 | 12676 | 0.130 |
Why?
|
Ceftriaxone | 1 | 2017 | 175 | 0.130 |
Why?
|
Osteosarcoma | 1 | 2022 | 896 | 0.130 |
Why?
|
Hemolysin Proteins | 1 | 2016 | 113 | 0.130 |
Why?
|
Apoprotein(a) | 1 | 2015 | 17 | 0.130 |
Why?
|
Nuclear Transfer Techniques | 1 | 2015 | 61 | 0.130 |
Why?
|
Diphosphonates | 1 | 2020 | 634 | 0.120 |
Why?
|
Spinal Neoplasms | 1 | 2022 | 703 | 0.120 |
Why?
|
Connective Tissue Diseases | 1 | 2018 | 285 | 0.120 |
Why?
|
Swine | 5 | 2017 | 5909 | 0.120 |
Why?
|
Malus | 1 | 2015 | 50 | 0.120 |
Why?
|
Cerebral Cortex | 2 | 2010 | 5775 | 0.120 |
Why?
|
Sphingosine | 1 | 2017 | 307 | 0.120 |
Why?
|
Aging | 1 | 2014 | 8702 | 0.120 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 1 | 2017 | 433 | 0.120 |
Why?
|
Electroencephalography | 1 | 2010 | 6242 | 0.120 |
Why?
|
Wound Infection | 1 | 2017 | 244 | 0.120 |
Why?
|
Ankle Brachial Index | 1 | 2015 | 163 | 0.120 |
Why?
|
Kyphoplasty | 1 | 2015 | 44 | 0.120 |
Why?
|
Neisseria gonorrhoeae | 1 | 2017 | 239 | 0.120 |
Why?
|
Parkinson Disease | 3 | 2019 | 2867 | 0.120 |
Why?
|
Neoplasms, Second Primary | 1 | 2022 | 1052 | 0.110 |
Why?
|
Hand | 1 | 2019 | 902 | 0.110 |
Why?
|
Eimeria | 1 | 2013 | 2 | 0.110 |
Why?
|
Coccidiostats | 1 | 2013 | 3 | 0.110 |
Why?
|
Coccidiosis | 1 | 2013 | 10 | 0.110 |
Why?
|
Spiro Compounds | 1 | 2014 | 68 | 0.110 |
Why?
|
Poultry Diseases | 1 | 2013 | 26 | 0.110 |
Why?
|
Lymphoma, B-Cell, Marginal Zone | 1 | 2015 | 178 | 0.110 |
Why?
|
Disease Models, Animal | 4 | 2017 | 18220 | 0.110 |
Why?
|
Stereoisomerism | 2 | 2011 | 611 | 0.110 |
Why?
|
Thrombocytopenia | 1 | 2021 | 1182 | 0.110 |
Why?
|
Intestinal Diseases, Parasitic | 1 | 2013 | 64 | 0.110 |
Why?
|
Cross-Over Studies | 1 | 2019 | 2082 | 0.110 |
Why?
|
Swine, Miniature | 1 | 2015 | 961 | 0.110 |
Why?
|
Stress, Mechanical | 4 | 2010 | 1674 | 0.110 |
Why?
|
Risk Factors | 7 | 2024 | 74239 | 0.110 |
Why?
|
Physical Endurance | 1 | 2015 | 366 | 0.100 |
Why?
|
Soft Tissue Neoplasms | 1 | 2021 | 1158 | 0.100 |
Why?
|
Erysipelas | 1 | 2012 | 3 | 0.100 |
Why?
|
Erysipelothrix | 1 | 2012 | 3 | 0.100 |
Why?
|
Blotting, Western | 5 | 2009 | 5032 | 0.100 |
Why?
|
Nitrogen | 1 | 2014 | 345 | 0.100 |
Why?
|
Neurons | 6 | 2010 | 9428 | 0.100 |
Why?
|
Reference Values | 1 | 2019 | 4921 | 0.100 |
Why?
|
Exercise Therapy | 1 | 2019 | 922 | 0.100 |
Why?
|
Swine Diseases | 1 | 2012 | 61 | 0.100 |
Why?
|
Device Removal | 1 | 2017 | 629 | 0.100 |
Why?
|
In Situ Hybridization | 3 | 2005 | 1900 | 0.100 |
Why?
|
Adult | 16 | 2023 | 221119 | 0.100 |
Why?
|
Leukocyte Count | 3 | 2011 | 1597 | 0.100 |
Why?
|
Spondylosis | 1 | 2012 | 84 | 0.090 |
Why?
|
Ergot Alkaloids | 1 | 2011 | 12 | 0.090 |
Why?
|
Treatment Outcome | 11 | 2023 | 64681 | 0.090 |
Why?
|
Chickens | 1 | 2013 | 857 | 0.090 |
Why?
|
Ergolines | 1 | 2011 | 57 | 0.090 |
Why?
|
Cross-Sectional Studies | 4 | 2023 | 26071 | 0.090 |
Why?
|
Internal Fixators | 1 | 2012 | 184 | 0.090 |
Why?
|
Laminectomy | 1 | 2012 | 225 | 0.090 |
Why?
|
Hepatitis B, Chronic | 1 | 2015 | 410 | 0.090 |
Why?
|
Animals, Genetically Modified | 1 | 2015 | 1558 | 0.090 |
Why?
|
Immunohistochemistry | 6 | 2009 | 11067 | 0.090 |
Why?
|
Fingers | 2 | 2010 | 506 | 0.090 |
Why?
|
Advance Care Planning | 1 | 2018 | 697 | 0.090 |
Why?
|
Evoked Potentials, Motor | 2 | 2010 | 464 | 0.090 |
Why?
|
Molecular Conformation | 1 | 2011 | 543 | 0.090 |
Why?
|
Cerebral Palsy | 1 | 2014 | 477 | 0.080 |
Why?
|
Drug Resistance, Bacterial | 1 | 2017 | 1048 | 0.080 |
Why?
|
Bone Neoplasms | 1 | 2022 | 2527 | 0.080 |
Why?
|
Channelopathies | 1 | 2009 | 30 | 0.080 |
Why?
|
Cell Culture Techniques | 3 | 2008 | 1662 | 0.080 |
Why?
|
Adolescent | 13 | 2023 | 88298 | 0.080 |
Why?
|
Bone Plates | 1 | 2012 | 465 | 0.080 |
Why?
|
Genome, Bacterial | 1 | 2014 | 785 | 0.080 |
Why?
|
Dominance, Cerebral | 1 | 2010 | 623 | 0.080 |
Why?
|
Nervous System Diseases | 1 | 2019 | 1663 | 0.080 |
Why?
|
Bone Screws | 1 | 2012 | 531 | 0.080 |
Why?
|
Rabbits | 3 | 2016 | 4750 | 0.080 |
Why?
|
Osteoarthritis, Knee | 1 | 2018 | 1236 | 0.080 |
Why?
|
Gene Expression Regulation, Bacterial | 1 | 2014 | 1131 | 0.070 |
Why?
|
Imaging, Three-Dimensional | 2 | 2018 | 4052 | 0.070 |
Why?
|
Sodium Channel Blockers | 2 | 2009 | 172 | 0.070 |
Why?
|
Patient Education as Topic | 1 | 2018 | 2317 | 0.070 |
Why?
|
Influenza A Virus, H5N1 Subtype | 1 | 2008 | 113 | 0.070 |
Why?
|
Dendrites | 1 | 2010 | 471 | 0.070 |
Why?
|
Kidney Transplantation | 1 | 2022 | 4242 | 0.070 |
Why?
|
Muscular Atrophy | 1 | 2010 | 334 | 0.070 |
Why?
|
Reaction Time | 2 | 2010 | 2087 | 0.070 |
Why?
|
SEER Program | 2 | 2022 | 1453 | 0.070 |
Why?
|
Radiography | 4 | 2018 | 6974 | 0.070 |
Why?
|
Pain Measurement | 4 | 2019 | 3549 | 0.070 |
Why?
|
Young Adult | 7 | 2021 | 59221 | 0.070 |
Why?
|
Time Factors | 6 | 2021 | 39957 | 0.070 |
Why?
|
Rats, Wistar | 1 | 2010 | 1848 | 0.070 |
Why?
|
Cells, Cultured | 6 | 2010 | 18926 | 0.070 |
Why?
|
Spectrin | 1 | 2006 | 170 | 0.060 |
Why?
|
Cats | 2 | 2004 | 974 | 0.060 |
Why?
|
Risk Assessment | 2 | 2024 | 24021 | 0.060 |
Why?
|
Liver Function Tests | 1 | 2007 | 525 | 0.060 |
Why?
|
Phosphopyruvate Hydratase | 1 | 2005 | 126 | 0.060 |
Why?
|
Bacterial Proteins | 2 | 2016 | 3836 | 0.060 |
Why?
|
Dinucleoside Phosphates | 1 | 2004 | 68 | 0.060 |
Why?
|
Chromatography, DEAE-Cellulose | 1 | 2004 | 81 | 0.060 |
Why?
|
Ibuprofen | 1 | 2006 | 229 | 0.060 |
Why?
|
Cues | 2 | 2010 | 874 | 0.060 |
Why?
|
Autonomic Pathways | 1 | 2004 | 31 | 0.060 |
Why?
|
Diagnostic Techniques and Procedures | 1 | 2006 | 219 | 0.060 |
Why?
|
Choice Behavior | 1 | 2010 | 825 | 0.060 |
Why?
|
Magnesium Sulfate | 1 | 2004 | 73 | 0.060 |
Why?
|
Physical Stimulation | 1 | 2005 | 517 | 0.060 |
Why?
|
Peripheral Arterial Disease | 1 | 2015 | 1275 | 0.060 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 2005 | 550 | 0.060 |
Why?
|
Radioimmunoassay | 1 | 2004 | 862 | 0.060 |
Why?
|
Transcranial Magnetic Stimulation | 2 | 2010 | 1473 | 0.050 |
Why?
|
Oligodeoxyribonucleotides | 1 | 2004 | 704 | 0.050 |
Why?
|
Decision Making | 1 | 2017 | 3931 | 0.050 |
Why?
|
Trypsinogen | 1 | 2002 | 84 | 0.050 |
Why?
|
Optic Nerve | 1 | 2006 | 571 | 0.050 |
Why?
|
Guinea Pigs | 1 | 2004 | 1308 | 0.050 |
Why?
|
Disease Outbreaks | 1 | 2012 | 1747 | 0.050 |
Why?
|
Spinal Canal | 1 | 2022 | 41 | 0.050 |
Why?
|
Cohort Studies | 3 | 2020 | 41496 | 0.050 |
Why?
|
Trypsin | 1 | 2002 | 486 | 0.050 |
Why?
|
Lung | 1 | 2020 | 9979 | 0.050 |
Why?
|
Motor Neurons | 1 | 2006 | 869 | 0.050 |
Why?
|
Caspases | 1 | 2004 | 878 | 0.050 |
Why?
|
Bioprosthesis | 1 | 2005 | 591 | 0.050 |
Why?
|
Calcium | 4 | 2010 | 5719 | 0.050 |
Why?
|
Influenza Vaccines | 1 | 2008 | 767 | 0.050 |
Why?
|
Cerebral Ventricles | 1 | 2003 | 542 | 0.050 |
Why?
|
Endopeptidases | 1 | 2004 | 766 | 0.040 |
Why?
|
Fluorescent Dyes | 2 | 2009 | 1901 | 0.040 |
Why?
|
Protein Kinase Inhibitors | 1 | 2017 | 5662 | 0.040 |
Why?
|
Protease Inhibitors | 1 | 2004 | 752 | 0.040 |
Why?
|
Mycophenolic Acid | 1 | 2022 | 350 | 0.040 |
Why?
|
Biopsy | 2 | 2015 | 6781 | 0.040 |
Why?
|
Pseudarthrosis | 1 | 2020 | 53 | 0.040 |
Why?
|
Brain Neoplasms | 1 | 2021 | 9025 | 0.040 |
Why?
|
Sensitivity and Specificity | 2 | 2018 | 14675 | 0.040 |
Why?
|
Hydrogels | 1 | 2006 | 720 | 0.040 |
Why?
|
Debridement | 1 | 2022 | 493 | 0.040 |
Why?
|
Predictive Value of Tests | 2 | 2021 | 15308 | 0.040 |
Why?
|
Body Mass Index | 3 | 2023 | 12952 | 0.040 |
Why?
|
Nerve Regeneration | 1 | 2005 | 796 | 0.040 |
Why?
|
Attention | 1 | 2010 | 2394 | 0.040 |
Why?
|
Transcription Factors | 2 | 2022 | 12099 | 0.040 |
Why?
|
Glucocorticoids | 2 | 2020 | 2159 | 0.040 |
Why?
|
Infarction, Middle Cerebral Artery | 1 | 2003 | 485 | 0.040 |
Why?
|
Atherosclerosis | 1 | 2015 | 3406 | 0.040 |
Why?
|
Liver Neoplasms | 1 | 2015 | 4309 | 0.040 |
Why?
|
Antibodies, Bacterial | 2 | 2016 | 1464 | 0.040 |
Why?
|
Follow-Up Studies | 5 | 2020 | 39126 | 0.040 |
Why?
|
Abscess | 1 | 2022 | 605 | 0.040 |
Why?
|
Directed Tissue Donation | 1 | 2018 | 18 | 0.040 |
Why?
|
Leukocytes, Mononuclear | 1 | 2004 | 1838 | 0.040 |
Why?
|
Mendelian Randomization Analysis | 1 | 2023 | 1010 | 0.040 |
Why?
|
Extremities | 1 | 2023 | 867 | 0.040 |
Why?
|
Biocompatible Materials | 1 | 2006 | 1683 | 0.040 |
Why?
|
Vital Capacity | 1 | 2020 | 970 | 0.040 |
Why?
|
Neuroglia | 1 | 2003 | 953 | 0.040 |
Why?
|
RNA | 1 | 2007 | 2709 | 0.030 |
Why?
|
Actinobacillus Infections | 1 | 2016 | 17 | 0.030 |
Why?
|
Health Records, Personal | 1 | 2018 | 127 | 0.030 |
Why?
|
Interferon-gamma | 1 | 2004 | 3155 | 0.030 |
Why?
|
Drug Resistance, Multiple, Bacterial | 1 | 2021 | 585 | 0.030 |
Why?
|
Synapses | 1 | 2006 | 1755 | 0.030 |
Why?
|
DNA Primers | 2 | 2012 | 2814 | 0.030 |
Why?
|
Liver Cirrhosis | 1 | 2006 | 1932 | 0.030 |
Why?
|
Skeletal Muscle Myosins | 1 | 2015 | 2 | 0.030 |
Why?
|
Advance Directives | 1 | 2018 | 249 | 0.030 |
Why?
|
RNA, Messenger | 3 | 2005 | 12747 | 0.030 |
Why?
|
Motor Activity | 1 | 2006 | 2712 | 0.030 |
Why?
|
Pancreatitis | 1 | 2002 | 1081 | 0.030 |
Why?
|
Hippocampus | 2 | 2006 | 3754 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 3 | 2018 | 36415 | 0.030 |
Why?
|
Myoglobin | 1 | 2015 | 159 | 0.030 |
Why?
|
Forced Expiratory Volume | 1 | 2020 | 1813 | 0.030 |
Why?
|
Osteogenesis | 1 | 2022 | 1273 | 0.030 |
Why?
|
Antibodies | 1 | 2002 | 2415 | 0.030 |
Why?
|
Rats, Inbred F344 | 1 | 2015 | 826 | 0.030 |
Why?
|
Toes | 1 | 2015 | 209 | 0.030 |
Why?
|
Myosin Heavy Chains | 1 | 2015 | 403 | 0.030 |
Why?
|
Maze Learning | 2 | 2006 | 481 | 0.030 |
Why?
|
Gene Expression | 3 | 2016 | 7571 | 0.030 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2023 | 15920 | 0.030 |
Why?
|
Specific Pathogen-Free Organisms | 1 | 2013 | 221 | 0.030 |
Why?
|
Intracellular Space | 1 | 2014 | 197 | 0.030 |
Why?
|
Uric Acid | 1 | 2019 | 807 | 0.030 |
Why?
|
Sigma Factor | 1 | 2014 | 176 | 0.030 |
Why?
|
Acriflavine | 1 | 2012 | 6 | 0.030 |
Why?
|
Genotype | 1 | 2007 | 12985 | 0.030 |
Why?
|
Histocytochemistry | 1 | 2013 | 697 | 0.030 |
Why?
|
Disability Evaluation | 1 | 2019 | 1834 | 0.020 |
Why?
|
Immunization | 1 | 2016 | 1218 | 0.020 |
Why?
|
Spinal Diseases | 1 | 2017 | 562 | 0.020 |
Why?
|
Colony-Forming Units Assay | 1 | 2012 | 351 | 0.020 |
Why?
|
Mucous Membrane | 1 | 2015 | 659 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 2017 | 3057 | 0.020 |
Why?
|
Serotyping | 1 | 2012 | 325 | 0.020 |
Why?
|
Embryo Transfer | 1 | 2015 | 522 | 0.020 |
Why?
|
Complementarity Determining Regions | 1 | 2012 | 149 | 0.020 |
Why?
|
Zebrafish | 1 | 2022 | 3000 | 0.020 |
Why?
|
Quantitative Trait Loci | 1 | 2019 | 2113 | 0.020 |
Why?
|
Back Pain | 1 | 2015 | 545 | 0.020 |
Why?
|
Prospective Studies | 3 | 2021 | 54435 | 0.020 |
Why?
|
Bone and Bones | 1 | 2021 | 2568 | 0.020 |
Why?
|
Protein Isoforms | 1 | 2015 | 1695 | 0.020 |
Why?
|
Models, Anatomic | 1 | 2014 | 683 | 0.020 |
Why?
|
Electric Stimulation | 1 | 2015 | 1736 | 0.020 |
Why?
|
Diabetic Angiopathies | 1 | 2015 | 805 | 0.020 |
Why?
|
Prognosis | 2 | 2023 | 29687 | 0.020 |
Why?
|
Dizocilpine Maleate | 1 | 2010 | 172 | 0.020 |
Why?
|
Xanthenes | 1 | 2009 | 71 | 0.020 |
Why?
|
Child | 4 | 2020 | 80152 | 0.020 |
Why?
|
Reoperation | 1 | 2020 | 4303 | 0.020 |
Why?
|
Sequence Deletion | 1 | 2014 | 1487 | 0.020 |
Why?
|
Brain Ischemia | 1 | 2003 | 3032 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2022 | 4190 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 2 | 2022 | 17897 | 0.020 |
Why?
|
Bone Density | 1 | 2022 | 3546 | 0.020 |
Why?
|
Reassortant Viruses | 1 | 2008 | 36 | 0.020 |
Why?
|
Cognition | 1 | 2006 | 6988 | 0.020 |
Why?
|
Protein Conformation | 1 | 2016 | 3933 | 0.020 |
Why?
|
Extracellular Space | 1 | 2010 | 563 | 0.020 |
Why?
|
Dog Diseases | 1 | 2009 | 141 | 0.020 |
Why?
|
Brain | 3 | 2004 | 27092 | 0.020 |
Why?
|
Virulence | 1 | 2012 | 1296 | 0.020 |
Why?
|
Species Specificity | 1 | 2012 | 2406 | 0.020 |
Why?
|
Recombinant Fusion Proteins | 1 | 2016 | 3726 | 0.020 |
Why?
|
Pain | 1 | 2022 | 5072 | 0.020 |
Why?
|
Transfection | 1 | 2015 | 5748 | 0.020 |
Why?
|
Independent Living | 1 | 2012 | 579 | 0.020 |
Why?
|
Temperature | 1 | 2014 | 2219 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2022 | 12474 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2004 | 7851 | 0.020 |
Why?
|
Adaptation, Physiological | 1 | 2014 | 1301 | 0.020 |
Why?
|
Escherichia coli Proteins | 1 | 2014 | 1058 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2004 | 9187 | 0.020 |
Why?
|
Equipment Design | 2 | 2005 | 3510 | 0.020 |
Why?
|
Astrocytes | 2 | 2006 | 1340 | 0.020 |
Why?
|
Stress, Physiological | 1 | 2014 | 1405 | 0.020 |
Why?
|
Molecular Structure | 1 | 2011 | 1875 | 0.020 |
Why?
|
Antigens, Bacterial | 1 | 2012 | 1140 | 0.020 |
Why?
|
Recombinant Proteins | 2 | 2009 | 6504 | 0.020 |
Why?
|
Women's Health | 1 | 2016 | 2070 | 0.020 |
Why?
|
Neocortex | 1 | 2010 | 416 | 0.020 |
Why?
|
Preoperative Care | 1 | 2015 | 2241 | 0.020 |
Why?
|
Models, Molecular | 1 | 2016 | 5406 | 0.020 |
Why?
|
Databases, Factual | 1 | 2021 | 7966 | 0.020 |
Why?
|
Movement Disorders | 1 | 2010 | 459 | 0.020 |
Why?
|
Base Sequence | 2 | 2009 | 12404 | 0.020 |
Why?
|
Cell Enlargement | 1 | 2005 | 59 | 0.020 |
Why?
|
Cell Division | 2 | 2003 | 4451 | 0.020 |
Why?
|
Rats, Long-Evans | 1 | 2006 | 380 | 0.020 |
Why?
|
Sex Factors | 1 | 2019 | 10553 | 0.020 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 2010 | 894 | 0.010 |
Why?
|
Sodium | 1 | 2010 | 1589 | 0.010 |
Why?
|
Cell Line | 2 | 2009 | 15545 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2016 | 13402 | 0.010 |
Why?
|
Aniline Compounds | 1 | 2009 | 1073 | 0.010 |
Why?
|
Growth Cones | 1 | 2004 | 117 | 0.010 |
Why?
|
Elasticity | 1 | 2005 | 655 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 2 | 2018 | 20588 | 0.010 |
Why?
|
Epithelial Cells | 1 | 2015 | 3671 | 0.010 |
Why?
|
Neutrophils | 2 | 2009 | 3763 | 0.010 |
Why?
|
Incidence | 1 | 2021 | 21365 | 0.010 |
Why?
|
Equipment Failure Analysis | 1 | 2005 | 846 | 0.010 |
Why?
|
Interleukin-18 | 1 | 2004 | 250 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2014 | 5773 | 0.010 |
Why?
|
Aspartic Acid Endopeptidases | 1 | 2004 | 309 | 0.010 |
Why?
|
Time | 1 | 2004 | 545 | 0.010 |
Why?
|
Body Weight | 1 | 2013 | 4618 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2006 | 10756 | 0.010 |
Why?
|
Interleukin-12 | 1 | 2004 | 578 | 0.010 |
Why?
|
Caspase 3 | 1 | 2004 | 730 | 0.010 |
Why?
|
Neurons, Afferent | 1 | 2004 | 498 | 0.010 |
Why?
|
Nerve Degeneration | 1 | 2006 | 747 | 0.010 |
Why?
|
Random Allocation | 1 | 2006 | 2393 | 0.010 |
Why?
|
Disease Progression | 1 | 2018 | 13511 | 0.010 |
Why?
|
Immunoenzyme Techniques | 1 | 2004 | 1703 | 0.010 |
Why?
|
Viral Proteins | 1 | 2008 | 1798 | 0.010 |
Why?
|
Pilot Projects | 1 | 2014 | 8642 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2012 | 4739 | 0.010 |
Why?
|
Neurofilament Proteins | 1 | 2003 | 334 | 0.010 |
Why?
|
Interleukin-4 | 1 | 2004 | 1154 | 0.010 |
Why?
|
Granulocytes | 1 | 2002 | 550 | 0.010 |
Why?
|
Mechanotransduction, Cellular | 1 | 2005 | 528 | 0.010 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2011 | 3770 | 0.010 |
Why?
|
Comorbidity | 1 | 2015 | 10516 | 0.010 |
Why?
|
Virus Replication | 1 | 2008 | 2426 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2018 | 20119 | 0.010 |
Why?
|
Cell Count | 1 | 2004 | 1831 | 0.010 |
Why?
|
Presenilin-1 | 1 | 2004 | 660 | 0.010 |
Why?
|
Microscopy, Confocal | 1 | 2006 | 1967 | 0.010 |
Why?
|
Cell Survival | 1 | 2010 | 5778 | 0.010 |
Why?
|
Amyloid Precursor Protein Secretases | 1 | 2004 | 619 | 0.010 |
Why?
|
Kidney | 1 | 2015 | 7033 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2010 | 2691 | 0.010 |
Why?
|
Obesity | 1 | 2022 | 12939 | 0.010 |
Why?
|
Smoking | 1 | 2015 | 9055 | 0.010 |
Why?
|
Prevalence | 1 | 2015 | 15721 | 0.010 |
Why?
|
Macrophages | 2 | 2003 | 5753 | 0.010 |
Why?
|
Mutation | 1 | 2002 | 30002 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2006 | 6223 | 0.010 |
Why?
|
Microglia | 1 | 2006 | 1358 | 0.010 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2006 | 2270 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2003 | 2635 | 0.010 |
Why?
|
Amyloidosis | 1 | 2003 | 865 | 0.010 |
Why?
|
United States | 1 | 2021 | 72339 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2009 | 10422 | 0.010 |
Why?
|
Child, Preschool | 1 | 2014 | 42224 | 0.010 |
Why?
|
Quality of Life | 1 | 2012 | 13367 | 0.010 |
Why?
|
Mice | 1 | 2016 | 81326 | 0.010 |
Why?
|
Chronic Disease | 1 | 2002 | 9319 | 0.000 |
Why?
|
Gene Expression Regulation | 1 | 2004 | 11856 | 0.000 |
Why?
|
Age Factors | 1 | 2003 | 18384 | 0.000 |
Why?
|
Antineoplastic Agents | 1 | 2009 | 13632 | 0.000 |
Why?
|
Algorithms | 1 | 2006 | 14025 | 0.000 |
Why?
|
Neoplasms | 1 | 2009 | 22140 | 0.000 |
Why?
|